본문 바로가기
KERD
논문KCI 등재

급성 심근경색증 환자에서 폐동맥 고혈압과 관상동맥중재술 후 임상 경과

The Impact of Pulmonary Hypertension on the Clinical Outcomes of Acute Myocardial Infarction after Percutaneous Coronary Intervention

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류내과학

초록

Background/Aims: Pulmonary hypertension (PH) in patients with heart failure contributes to a poor prognosis. However, the role of PH in the long-term clinical outcome is unclear in those with acute myocardial infarction (AMI). The clinical significance of elevated right ventricular systolic pressure (RVSP) on routine echocardiography is underestimated. Methods: This study enrolled 2,526 AMI patients (65.1 ± 12.7 years; 1,757 males [69.6%]) from the Korean AMI registry who underwent successful percutaneous coronary intervention and pre-discharge transthoracic echocardiography (TTE). The patients were divided into four groups according to the RVSP on TTE: normal RVSP (RVSP < 35 mmHg, n = 1,695), mild PH (35 ≤ RVSP < 45 mmHg, n = 601), moderate PH (45 ≤ RVSP < 70 mmHg, n = 211), and severe PH (RVSP ≥ 70 mmHg, n = 19). Major adverse cardiac events (MACE) were compared among the four groups. Results: During the 3-year clinical follow-up period, MACE occurred in 562 patients (22.2%), including 321 (18.9%), 145 (24.1%), 83 (39.3%), and 13 patients (68.4%) in the normal RVSP and mild, moderate, and severe PH groups, respectively. On multivariate analysis, independent factors for MACE were moderate or severe PH, age ≥ 65 years, Killip class ≥ III, left ventricular ejection fraction < 40%, hypertension, and diabetes. Conclusions: Measuring RVSP is useful for stratifying the risk of patients with AMI; MACE occurred in patients with moderate or severe PH.

Abstract

Background/Aims: Pulmonary hypertension (PH) in patients with heart failure contributes to a poor prognosis. However, the role of PH in the long-term clinical outcome is unclear in those with acute myocardial infarction (AMI). The clinical significance of elevated right ventricular systolic pressure (RVSP) on routine echocardiography is underestimated. Methods: This study enrolled 2,526 AMI patients (65.1 ± 12.7 years; 1,757 males [69.6%]) from the Korean AMI registry who underwent successful percutaneous coronary intervention and pre-discharge transthoracic echocardiography (TTE). The patients were divided into four groups according to the RVSP on TTE: normal RVSP (RVSP < 35 mmHg, n = 1,695), mild PH (35 ≤ RVSP < 45 mmHg, n = 601), moderate PH (45 ≤ RVSP < 70 mmHg, n = 211), and severe PH (RVSP ≥ 70 mmHg, n = 19). Major adverse cardiac events (MACE) were compared among the four groups. Results: During the 3-year clinical follow-up period, MACE occurred in 562 patients (22.2%), including 321 (18.9%), 145 (24.1%), 83 (39.3%), and 13 patients (68.4%) in the normal RVSP and mild, moderate, and severe PH groups, respectively. On multivariate analysis, independent factors for MACE were moderate or severe PH, age ≥ 65 years, Killip class ≥ III, left ventricular ejection fraction < 40%, hypertension, and diabetes. Conclusions: Measuring RVSP is useful for stratifying the risk of patients with AMI; MACE occurred in patients with moderate or severe PH.

참고문헌 (39)

  1. "Cause of death statistics" (2022)[URL]
  2. "Cause of death statistics 2020" (2021)[URL]
  3. Mollema SA, "Prognostic value of echocardiography after acute myocardial infarction", Heart, 95, pp.1732~1745 (2009)
  4. Otterstad JE, "Prognostic value of two-dimensional echocardiography and N-terminal proatrial natriuretic peptide following an acute myocardial infarction. Assessment of baseline values (2-7 days) and changes at 3 months in patients with a preserved systolic function", Eur Heart J, 23, pp.1011~1020 (2002)
  5. Subias PE, "Comments on the 2015 ESC", ERS guidelines for the diagnosis and treatment of pulmonary hypertension, 2016, pp.69, 102~108
  6. Rudski LG, "Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography", J Am Soc Echocardiogr, 23, pp.685~788 (2010)
  7. Gupta NK, "Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease", Lung India, 28, pp.105~109 (2011)
  8. Merlos P, "Echocardiographic estimation of pulmonary arterial systolic pressure in acute heart failure. Prognostic implications", Eur J Intern Med, 24, pp.562~567 (2013)
  9. Yin D, "Comparison of pulmonary artery pressure measurement with doppler echocardiography or with right heart catheterization in patients with congenital heart disease", Front Pediatr, 7, pp.421~ (2019)
  10. Galiè N, "2015 ESC", ERS guidelines for the diagnosis and treatment of pulmonary hypertension:the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT), 2016, pp.37, 67~119
  11. Greiner S, "Reliability of noninvasive assessment of systolic pulmonary artery pressure by Doppler echocardiography compared to right heart catheterization:analysis in a large patient population", J Am Heart Assoc, 3, pp.e001103~ (2014)
  12. Dupuis J, "Pathophysiology and clinical relevance of pulmonary remodelling in pulmonary hypertension due to left heart diseases", Can J Cardiol, 31, pp.416~429 (2015)
  13. Lam CS, "Pulmonary hypertension in heart failure with preserved ejection fraction : a community-based study", J Am Coll Cardiol, 53, pp.1119~1126 (2009)
  14. Mutlak D, "Utility of pulmonary hypertension for the prediction of heart failure following acute myocardial infarction", Am J Cardiol, 109, pp.1254~1259 (2012)
  15. Fan XT, "Effect of elevated pulmonary artery systolic pressure on short-term prognosis in patients with acute myocardial infarction", Angiology, 71, pp.567~572 (2020)
  16. Larisch A, "Mental distress and wish for psychosomatic treatment of patients with pulmonary hypertension", Psychother Psychosom Med Psychol, 64, pp.384~389 (2014)
  17. Kim JH, "Multicenter cohort study of acute myocardial infarction in Korea-interim analysis of the Korea Acute Myocardial Infarction Registry-National Institutes of Health Registry", Circ J, 80, pp.1427~1436 (2016)
  18. Thygesen K, "Fourth universal definition of myocardial infarction(2018)", J Am Coll Cardiol, 72, pp.2231~2264 (2018)
  19. Scanlon PJ, "ACC", AHA guidelines for coronary angiography. A report of the American College of Cardiology, J Am Coll Cardiol, pp.1999, 33[DOI]
  20. Kini AS, "Coronary angiography, lesion classification and severity assessment", Cardiol Clin, 24, pp.153~162 (2006)
  21. Lang RM, "Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging", Eur Heart J Cardiovasc Imaging, 16, pp.233~270 (2015)
  22. McGoon M, "Screening, early detection, and diagnosis of pulmonary arterial hypertension : ACCP evidence-based clinical practice guidelines", Chest, 126(Suppl 1), pp.14S~34S (2004)[DOI]
  23. Willens HJ, "Noninvasive differentiation of pulmonary arterial and venous hypertension using conventional and Doppler tissue imaging echocardiography", J Am Soc Echocardiogr, 21, pp.715~719 (2008)
  24. Floyd KC, "Age-based differences of percutaneous coronary intervention in the drug-eluting stent era", J Interv Cardiol, 19, pp.381~387 (2006)
  25. Guagliumi G, "Outcome in elderly patients undergoing primary coronary intervention for acute myocardial infarction: results from the controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial", Circulation, 110, pp.1598~1604 (2004)
  26. Yao J, "Prediction factors of 6-month poor prognosis in acute myocardial infarction patients", Front Cardiovasc Med, 7, pp.130~ (2020)
  27. 김은정, "급성 심근경색증 환자의 예후인자로서 내원 시 혈당의 유용성", 대한내과학회지, 79(1), pp.23~31 (2010), 대한내과학회
  28. Milazzo V, "Diabetes mellitus and acute myocardial infarction : impact on short and long-term mortality", Adv Exp Med Biol, 1307, pp.153~169 (2021)
  29. Arques S, "Current clinical applications of spectral tissue Doppler echocardiography (E", E' ratio) as a noninvasive surrogate for left ventricular diastolic pressures in the diagnosis of heart failure with preserved left ventricular systolic function, 2007, pp.5, 16~
  30. Armstrong DW, "Factors influencing the echocardiographic estimate of right ventricular systolic pressure in normal patients and clinically relevant ranges according to age", Can J Cardiol, 26, pp.e35~e39 (2010)
  31. Dokainish H, "Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters", Circulation, 109, pp.2432~2439 (2004)
  32. Minicucci MF, "Heart failure after myocardial infarction : clinical implications and treatment", Clin Cardiol, 34, pp.410~414 (2011)
  33. Kontos MC, "Predictive power of systolic function and congestive heart failure in patients with patients admitted for chest pain without ST elevation in the troponin era", Am Heart J, 156, pp.329~335 (2008)
  34. Halkin A, "Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction : the CADILLAC risk score", J Am Coll Cardiol, 45, pp.1397~1405 (2005)
  35. Im MS, "Different prognostic factors according to left ventricular systolic function in patients with acute myocardial infarction", Int J Cardiol, 221, pp.90~96 (2016)
  36. Rott D, "Improved survival of patients with acute myocardial infarction with significant left ventricular dysfunction undergoing invasive coronary procedures", Am Heart J, 141, pp.267~276 (2001)
  37. Daneault B, "Comparison of three-year outcomes after primary percutaneous coronary intervention in patients with left ventricular ejection fraction <40% versus ≥ 40% (from the HORIZONS-AMI trial)", Am J Cardiol, 111, pp.12~20 (2013)
  38. Fang JC, "World Health Organization pulmonary hypertension group 2: pulmonary hypertension due to left heart disease in the adult--a summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation", J Heart Lung Transplant, 31, pp.913~933 (2012)
  39. Writing Committee Members, "2013 ACCF", AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation, Circulation, pp.2013, 128[DOI]

관련 논문AI추천

급성 심근경색증 환자에서 예후 예측인자로서 좌심방 용적지수강정채, 김계훈, 김주한, 박종춘, 안영근, 윤현주, 이정애, 이지선, 정명호, 조정관, 최진수, 홍영준대한내과학회 · 대한내과학회지2014 · 제86권 제1호급성 심근경색증 환자에서 관상동맥 중재술 후 허혈성 심근병증 예측인자김계훈, 김민철, 김용철, 김주한, 김혜숙, 박종춘, 손석준, 심두선, 안영근, 윤현주, 정명호, 조재영, 홍영준대한내과학회 · 대한내과학회지2020 · 제95권 제3호The predictive value of echocardiography for chronic thromboembolic pulmonary hypertension after acute pulmonary embolism in Korea박진섭, 안진희, 오준혁, 이한철, 이혜원, 차광수, 최정현, 홍택종대한내과학회 · The Korean Journal of Internal Medicine2017 · 제32권 제1호한국인 급성 심근경색증 환자에서 좌심실 비대의 형태학적 분류에 따른 임상경과의 차이김계훈, 김민철, 김용철, 김주한, 김희정, 박종춘, 손석준, 심두선, 안영근, 윤현주, 정명호, 조재영, 홍영준대한내과학회 · 대한내과학회지2020 · 제95권 제6호Improvement of Left Ventricular Ejection Fraction and Pulmonary Hypertension Are Significant Prognostic Factors in Heart Failure with Reduced Ejection Fraction PatientsHee-Jin Kwon, In-Whan Seong, Jae-Hwan Lee, Jae-Hyeong Park, Jin Joo Park한국심초음파학회 · Journal of Cardiovascular Imaging2019 · 제27권 제4호흡연을 하는 급성 심근경색증 환자에서 일년 후 사망 예측인자김민철, 김영조, 김종진, 김주한, 설수영, 손석준, 심두선, 안영근, 이승헌, 정명호, 조명찬, 홍영준대한내과학회 · 대한내과학회지2018 · 제93권 제4호

이 간행물의 다른 논문 (7건)